Dr. Seufer-Wasserthal brings more than 20 years of experience in business development and licensing, as well as enzyme technology and chemistry, to Intrexon.Prior to joining Intrexon, Dr. Seufer-Wasserthal was Senior Vice President of Pharmaceuticals at Codexis, Inc., where he was responsible for closing numerous licensing, research and supply agreements, and adapting IP strategy to increase account penetration. Before Codexis, Inc., Dr. Seufer-Wasserthal managed drug discovery collaborations, licensed pre-clinical candidates and purchased services for drug development projects as Senior Vice President of Clinical Development at Morphochem AG.He holds a Ph.D. in organic chemistry from the Technical University of Graz.
Organization Name | Title At Company | Start Date | End Date | |
---|---|---|---|---|
Willow Biosciences | President and Chief Executive Officer | Nov 1, 2022 | — | Detail |